Kumulus Vape (ALVAP) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
20 Apr, 2026Executive summary
Net income reached €1.0M for 2025, maintaining profitability despite a challenging environment.
Revenue declined 5.2% year-over-year to €57.5M, reflecting macroeconomic and sector-specific pressures.
Cash position strengthened to €5.2M, while financial debt reduced to €3.5M.
The group demonstrated resilience, preserving its business fundamentals and preparing for future growth.
Financial highlights
Revenue: €57.5M in 2025, down 5.2% from €60.7M in 2024.
Gross margin: €12.5M (21.7% of revenue), down from €14.3M (23.6%).
EBITDA: €2.5M (4.4% of revenue), down 38.1% year-over-year.
Operating income: €2.0M (3.4% of revenue), down 45.3%.
Net income: €1.0M (1.7% of revenue), down 62.3%.
Outlook and guidance
No public quantitative targets for 2026, but focus on returning to growth.
Launch of Labster, a new in-house consumables lab, to drive margin optimization and product innovation.
Continued expansion of the retail network and digital tools to support omnichannel strategy.
Latest events from Kumulus Vape
- Stable Q3 revenue at €14.8M; B2B growth and regulatory risks shape outlook.ALVAP
Q3 2025 TU5 Nov 2025 - Revenue and net income fell, with stable gross margin but negative operating cash flow.ALVAP
H1 202525 Sep 2025 - Q1 2025 revenue declined 9% to €13.9M as franchise strategy and BtoB focus intensified.ALVAP
Q1 20257 Jul 2025 - Q3 revenue at €14.8M, 70% of annual target met; strong Q4 expected with €64M goal reaffirmed.ALVAP
Q3 2024 TU13 Jun 2025 - H1 2024 net income was €1.05M on €30.1M revenue, with ongoing franchise integration.ALVAP
H1 202413 Jun 2025 - Net income up 41% to €2.6M, with margin gains and a €62M revenue target for 2025.ALVAP
H2 20246 Jun 2025